Skip to main content

Contact Seyyed-Reza Sadat-Ebrahimi

From: The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial

Contact corresponding author